Oral, nasal and pulmonary dosage formulations of copolymer 1

Details Oral, nasal and pulmonary dosage formulations of copolymer 1 Oral, nasal and pulmonary dosage formulations of copolymer 1

2006-04-04

2006-04-04

Chan, Christina (Department: 1644)

Perfume compositions

Perfume compositions

With preservative, stabilizer, or fixative

C424S452000, C424S465000, C424S474000, C424S491000, C424S494000, C424S185100, C427S002160, C427S002190, C427S002210, C514S012200

Reexamination Certificate

active

07022663

ABSTRACT:
Pharmaceutical compositions useful for treating autoimmune diseases in a mammal comprising as an active ingredient a therapeutically effective amount of Copolymer 1, and microcrystalline cellulose are disclosed. Processes for the manufacture of such compositions are also disclosed.

REFERENCES:
patent: 3849550 (1974-11-01), Teitelbaum et al.
patent: 3991210 (1976-11-01), Shea
patent: 4129666 (1978-12-01), Wizerkaniuk
patent: 4339431 (1982-07-01), Gaffar
patent: 5075115 (1991-12-01), Brine
patent: 5204099 (1993-04-01), Barbier et al.
patent: 5554372 (1996-09-01), Hunter et al.
patent: 5583031 (1996-12-01), Stern
patent: 5591629 (1997-01-01), Rodriguez et al.
patent: 5623052 (1997-04-01), McLean et al.
patent: 5627206 (1997-05-01), Hupe et al.
patent: 5668117 (1997-09-01), Shapiro et al.
patent: 5719296 (1998-02-01), Acton, III et al.
patent: 5734023 (1998-03-01), Nag et al.
patent: 5800808 (1998-09-01), Konfino et al.
patent: 5858964 (1999-01-01), Aharoni et al.
patent: 5886156 (1999-03-01), McLean et al.
patent: 5958972 (1999-09-01), Hupe et al.
patent: 5965600 (1999-10-01), Sato et al.
patent: 5981589 (1999-11-01), Konfino et al.
patent: 6024981 (2000-02-01), Khankari et al.
patent: 6048898 (2000-04-01), Konfino et al.
patent: 6054430 (2000-04-01), Konfino et al.
patent: 6162800 (2000-12-01), Dolle et al.
patent: 6214791 (2001-04-01), Arnon et al.
patent: 6342476 (2002-01-01), Konfino et al.
patent: 6362161 (2002-03-01), Konfino et al.
patent: 6514938 (2003-02-01), Gad et al.
patent: 6800285 (2004-10-01), Rodriguez et al.
patent: 6800287 (2004-10-01), Gad et al.
patent: 6844314 (2005-01-01), Eisenbach-Schwartz et al.
patent: 2002/0037848 (2002-03-01), Eisenbach-Schwartz et al.
patent: 2002/0055466 (2002-05-01), Aharoni et al.
patent: 2002/0077278 (2002-06-01), Yong et al.
patent: 2002/0107388 (2002-08-01), Vandenbark
patent: 2002/0115103 (2002-08-01), Gad et al.
patent: 2002/0182210 (2002-12-01), Rodriguez et al.
patent: 2003/0004099 (2003-01-01), Eisenbach-Schwartz et al.
patent: 2003/0170729 (2003-09-01), Klinger
patent: 2004/0006022 (2004-01-01), Strominger et al.
patent: 2004/0106554 (2004-06-01), Konfino et al.
patent: 2005/0014694 (2005-01-01), Yong et al.
patent: 2005/0019322 (2005-01-01), Rodriguez et al.
patent: 2005/0038233 (2005-02-01), Gad et al.
patent: 0383620 (1990-08-01), None
patent: 0359783 (1995-11-01), None
patent: WO8810120 (1988-12-01), None
patent: WO9202543 (1992-02-01), None
patent: WO9403484 (1994-02-01), None
patent: WO9426774 (1994-11-01), None
patent: WO9526980 (1995-10-01), None
patent: WO9531990 (1995-11-01), None
patent: WO9531997 (1995-11-01), None
patent: WO9533475 (1995-12-01), None
patent: WO 98 30227 (1998-07-01), None
patent: WO9830227 (1998-07-01), None
patent: WO0005249 (2000-02-01), None
patent: WO0005250 (2000-02-01), None
patent: WO0018794 (2000-04-01), None
patent: WO0020010 (2000-04-01), None
patent: WO0027417 (2000-05-01), None
patent: WO0152878 (2001-07-01), None
patent: WO0160392 (2001-08-01), None
patent: WO0185797 (2001-11-01), None
patent: WO0193828 (2001-12-01), None
patent: WO0193893 (2001-12-01), None
patent: WO0197846 (2001-12-01), None
patent: WO02076503 (2002-10-01), None
patent: WO03048735 (2003-06-01), None
Kropshofer et al., “Self-Peptides from Four HLA-DR Alleles Share Hydrophobic Anchor Residues Near the NH2-Terminal Including Proline as a Stop Signal for Trimming”,J. Immunol., 1993, 151:4732-4742.
Henry, Celia M., “Special Delivery”,Chem. and Eng. News, Sep. 18, 2000, 49-54.
Cohen, “Fundamental Immunology”,Systemic Autoimmunity, 5thEd., 1999, 1083.
Fridkis-Hareli et al., “Binding of random copolymers of three amino acids to class II MHC molecules”,Intl. Immunol., 1999, 11(5):633-641.
Li, et al., “Glatiramer acetate blocks the activation of THP-1 cells by interferon-y”,Eur. J. Pharmacol., 1998, 342: 303-310.
Zisman, et al., “Dichotomy between the T and the B cellepitopes of the synthetic polypeptide (T,G)-A--L”,Eur. J. Immunol., 1994, 24(10):2497-2505 (Abstract).
Deeb, et al., “Comparison of Freund's and Ribi adjuvants for inducing antibodies to the synthetic antigen (TG)-AL in rabbits”,J. Immunol. Methods, 1992, 152(1): 105-113 (Abstract).
Zisman et al., “Direct Binding of a synthetic multichain polypeptide to class II Major Histocompatibility Complex Molecules on Antigen-Presenting Cells and stimulation of a specific T-cell line require processing of the polypeptide”,Proc. Natl. Acad. Sci. USA, 1991, 88(21):9732-9742 (Abstract).
Matsunaga et al., “Complementation of class II A alleles in the immune response to (Glu-Lys-Tyr) polymers”,Yokohama Med. Bull., 1988, 39(1-2):9-19(Abstract).
De Kruyff et al., “Analysis of T Cell Responses to Poly-L (GluLys) at the Clonal Level. I. Presence of Responsive Clones in Nonresponder Mice”,Eur. J. Immunol., 1987, 17 (8): 1115-1120 (Abstract).
Lai et al., “Complementation of Class II A alleles in the immune response to (GluLysTyr) polymers”,Exp. Clin. Immuogenet., 1986, 3(1):38-48 (Abstract).
Lai, et al., “Monoclonal T cell responses to two epitopes on a single immunogen controlled by two distinct genes”,J. Immunol., 1986, 136(10):3799-3804 (Abstract).
Trannoy et al., “Epitope-specific regulation of the T cell repertoire: carrier recognition in association with I-E or I-A does not influence the restriction of hapten-specific T cells”,Eur. J. Immunol., 1985, 15(12):1215-1221 (Abstract).
Falo et al., “Analysis of antigen presentation by metabolically inactive accessory cells and their isolated membranes”,Proc. Natl. Acad. Sci. USA, 1985, 82(19);6647-6651 (Abstract).
Babu et al., “Ir gene control of T and B Cell Responses to Determinants in (Glu Lys Ala) Terpolymer”,J. Immunogenet., 1984, 11(3-4): 251-254.
Babu et al., Reevaluation of response patterns of nonresponder mice to GLPhe polymers:,Immunogen., 1983, 18(1):97-100 (Abstract).
Herzenberg et al., “Lack of immune response gene control for induction of epitope specific suppression by TGAL antigen”,Nature, 1982, 295: 329-331 (Abstract).
Baxevanis et al., “Genetic Control of T-Cell Proliferative Responses to Poly (Glu40Ala60) and Poly (Glu51Lys34Tyr15): Subregion-Specific Inhibition of the Responses with Monoclonal Ia Antibodies”,Immunogenetics, 1980, 11: 617-628.
Maurer et al., “Interpretation of immune responses of mice to poly(Glu55Lys37Leu8) and the terpolymers poly (Glu55Lys37Leu8) and poly (Glu56Lys37Ser7)”,Clin. Immunol. Immunopathol., 1980, 15(3):34-356 (Abstract).
Ju et al., “Idiotypic analysis of antibodies against the terpolymer L-glutamic acid 60-L-alanine30-L-tyrosine10 (GAT). IV. Induction of CGAT idiotype following immunization with various synthetic polymers containing glutamic acid and tyrosine”,Eur. J. Immunol., 1979, 9(7): 553-560 (Abstract).
Schwartz et al., “Gene complementation in the T lymphocyte proliferative response to poly (Glu57Lys38Tyr5): Evidence for effects of polymer handling and gene dosage”,J. Immunol., 1979, 123(1):272-278 (Abstract).
Teitelbaum, et al., “Suppression of Experimental Allergic Encephalomyelitis by a Synthetic Polypeptide”,Eur. J. Immunol., 1971, 1, 242-248.
Teitelbaum, et al., “Suppression of Experimental Allergic Encephalomyelitis by a Synthetic Polypeptide”,Israel J. Med. Sci., 1971, 7, 630-631 (Abstract).
Arnon, et al., “Suppression of Experimental Allergic Encephalomyelitis by a Synthetic Copolymer Immunological Cross Reactive with Basic Encephalitogen”,Israel J. Med. Sci., 1972, 8, 1759-1760.
Teitelbaum, et al., “Protection Against Experimental Allergic Encephalomyelitis”,Nature, 1972, 240, 564-566.
Webb, et al., “Further Studies on the Suppression of Experimental Allergic Encephalomyelitis by Synthetic Copolymer”,Israel J. Med. Sci., 1972, 8, 656-657.
Teitelbaum, et al., “Suppression of Experimental Allergic Encephalomyelitis

Affiliated with

Also associated with

Rating

Oral, nasal and pulmonary dosage formulations of copolymer 1 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Oral, nasal and pulmonary dosage formulations of copolymer 1, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oral, nasal and pulmonary dosage formulations of copolymer 1 will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3594594